Diabetic retinopathy (DR) is a major complication of both Type 1 and Type 2 diabetes mellitus (T1DM and T2DM). Disease progression can result in visual impairment, primarily due to diabetic macular edema (DME) or proliferative diabetic retinopathy (PDR). Although several ocular treatments are available for DME, a subset of patients fails to respond, reflecting the multifactorial, complex, and systemic nature of...
Wet age-related Macular Degeneration (AMD), characterized by macular neovascularization that leads to fluid leakage and retinal hemorrhage causing severe and sometimes irreversible visual damage, is one of the biggest causes of blindness in developed countries (1). Treatment with anti-vascular endothelial growth factors (anti- VEGF) has been revolutionary, but not all patients respond completely to treatment an...
Documento: RD-gdl 0010 GER Portugal versão 1.2 Out-2023 (Este Documento esteve em discussão no GER e na SPO até 31 de Outubro de 2023 para recolha de opinião de todos os interessados de forma a melhorar o seu conteúdo e obter o maior consenso possível. A todos os colegas que deram o seu contributo, o grupo de trabalho agradece a colaboração.)
Diabetic macular edema (DME) is the main cause of visual impairment associated with diabetic retinopathy (DR) and macular laser, during approximately three decades, and was the single treatment option. More recently, intravitreous injections of anti-angiogenics and corticosteroids modified the treatment paradigm associated with significant vision improvements. Nevertheless, not all patients respond satisfactori...
Introduction: Contrast rapid sequence angiography with fluorescein or indocyanine green (ICG) is a diagnostic procedure commonly used in ophthalmology. Adverse reactions to fluorescein and ICG are rare and may be classified as toxic, of hypersensitivity and non-specific. The evaluation and management of a patient with an adverse reaction is a challenge for the majority of ophthalmologists, as is the assessment ...
Introdução O edema macular diabético (EMD), uma manifestação da retinopatia diabética, é a principal causa de perda da acuidade visual em doentes com Diabetes Mellitus. O papel do fator de crescimento do endotélio vascular é amplamente conhecido e as terapêuticas dirigidas à sua inibição, através de injeção intravítrea, têm eficácia e segurança comprovadas. No entanto alguns doentes apresentam uma má resposta a...
Introduction: To evaluate the safety and impact on visual acuity, retinal and choroidal morphology of simultaneous cataract surgery and intravitreal anti-vascular endothelial growth factor on patients with visually significant cataracts and previously treated exudative age-related macular degeneration.Material and Methods: Prospective study, which included 21 eyes of 20 patients with exudative age-related macul...
No mundo contemporâneo, milhares de pessoas se movem diariamente, por vontade própria ou forçadamente, dentro dos seus países e entre os vários países do mundo. Ao longo de toda sua história, Portugal também viveu e vive o fenômeno migratório com saída de portugueses/as e chegada de imigrantes de diversos grupos étnico-culturais e diversas nacionalidades. As pessoas quando migram deixam o seu espaço conhecido e...
Aim: To evaluate the effect of intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents on the development of sustained ocular hypertension (OHT) in patients with neovascular age-related macular degeneration (AMD). Methods: A retrospective study of patients with neo- vascular AMD who received unilateral intravitreal anti-VEGF treatment was performed. Fellow non-injected eyes were used as controls...
Introdução: A coriorretinopatia posterior placóide sifílitica aguda (CPPSA) é uma manifesta- ção rara de sífilis ocular caracterizada por uma lesão macular de formato placóide, provavelmen- te relacionada com a resposta imunológica ao agente infeccioso, no entanto a patogénese per- manece desconhecida. Através de uma abordagem diagnóstica multimodal os autores pretendem caracterizar as alteraçõe...